2. 2
Learning Objectives
Describe the association between STIs and HIV
Identify the etiologies and mode of transmission
of some of the most common STIs
Understand the major symptoms of commonly
encountered STIs
Determine the most effective treatment
approaches for commonly encountered STIs
3. 3
STI versus STD
STI – Infections acquired through sexual
intercourse (may be symptomatic or
asymptomatic)
STD – Symptomatic disease acquired through
sexual intercourse
STI is most commonly used because it applies
to both symptomatic and asymptomatic
infections
4. 4
Introduction
Most STIs are treatable
However, resistance to many of the older antibiotics is a
challenge
Other have no cure, such as herpes, genital warts, HIV
Many STIs can lead to related conditions such as:
Pelvic inflammatory disease
Cervical cancer
Complications in pregnancy
STIs can have socio-economic consequences
Education about these diseases and prevention are
important
5. 5
Link Between STIs & HIV/AIDS
STIs facilitate HIV transmission and acquisition
Chancroid, chlamydia, gonorrhea, syphilis, and
trichomoniasis may increase the risk of HIV
transmission by two to nine times
STI control reduces transmission of HIV
The prevalence of HIV in heterosexual populations is
higher in Africa than in Europe and the US where
STIs are more often treated and cured
6. 6
Link Between STIs & HIV/AIDS (2)
STIs and HIV infection share similar
epidemiologic determinants
Result from risky sexual behavior
Affect the same age group
HIV affects the clinical presentation and
management of STIs
In people with HIV infection, other STIs may be more
resistant to treatment
7. 7
Interventions to Reduce Transmission
Decrease duration of infectivity
Early diagnosis & curative or suppressive therapy
Decrease efficiency of transmission
Promote safer sexual behavior
Decrease susceptible persons’ exposure rate to
infected individuals
Counsel to modify sexual behavior
9. 9
Syndromic Approach to
STI Management
Identification of clinical syndrome
Giving treatment targeting all the locally known
pathogens which can cause the syndrome
10. 10
Syndromic Approach to
STI Management (2)
Advantages
Simple, rapid and inexpensive
Complete care offered at first visit
Patients are treated for possible mixed infections
Accessible to a broad range of health workers
Avoids unnecessary referrals to hospitals
Disadvantages
Over-treatment
Asymptomatic infections are missed
11. 11
STI Syndromes
1. Urethral discharge or burning on urination in
men
2. Vaginal discharge
3. Genital ulcer in men and women
4. Lower abdominal pain in women
5. Scrotal swelling
6. Inguinal bubo
13. Patient complains
of urethral discharge
or dysuria
Take history
& Do P/E; milk urethra
if necessary
Discharge
confirmed
Other STIs
present?
•Educate and counsel
•Offer VCT
•Review if symptoms
persist
•Promote and provide
condoms
Use appropriate
flow chart
Treat for gonorrhea
and chlamydia
•Educate
•Counsel
•Promote and provide condoms
•Offer VCT
•Partner management
•Advise to return in 7 days
if discharge persists
yes
No No
Yes
Urethral Discharge
Syndrome
14. 14
Recommended Treatment for Urethral
Discharge and Burning on Urination
Ciprofloxacin 500 mg po stat, or Spectinomycin
2g IM stat
and
Doxycycline 100 mg po BID for 7 days, or
Tetracycline 500 mg po QID for 7 days, or
Erythromycin 500 mg po QID for 7 days if the
patient has contraindications for Tetracyclines
15. Persistent or
Recurrent Urethral
Discharge in Men
Take history
and examine
Does history
confirm reinfection
or poor compliance
Treat for trichomonas
vaginalis
•Educate/ counsel
•Promote and provide condoms
•Return in 7 days
Improved
Discharge confirmed
Patient complains of
Persistent/ recurrent
Urethral discharge or dysuria
Other STIs
present
Use appropriate
flow chart
Repeat
urethral discharge
treatment
Refer
•Educate/ counsel
•Promote and provide condoms
• Offer VCT
Yes
No
No
Yes
Yes
•Educate/ counsel
•Promote and
provide condoms
• Offer VCT
No
Yes
No
17. 17
Patient complains
of vaginal discharge or
vulval itching/ burning
Abnormal discharge present
Take history, examine patient
(external speculum and bimanual)
and assess risk
Lower abdominal tenderness
or cervical motion tenderness
Was risk assessment positive?
Is discharge from the cervix?
Vulval edema/curd like discharge
Erythema excoriation present
Treat for bacterial vaginosis
and trichomoniasis
Treat for chlamydia, gonorrhea,
bacterial vaginosis and trichomoniasis
Use flow chart for lower abdominal pain
Educate
Counsel
Promote and provide condoms
Offer VCT
Educate
Counsel
Promote and provide condoms
Offer VCT
Treat for
Candida
albicans
No
Yes
Yes
Yes
No
No
No
Yes
Vaginal Discharge
18. 18
Recommended Treatment for
Vaginal Discharge
Metronidazole 500mg PO BID for
7 days
and
Clotrimazole vaginal tabs 200mg
at bed time for 3 days
Ciprofloxacin 500mg PO stat, or
Spectinomycin 2gm IM stat
and
Doxycycline 100mg PO BID for 7
days
and
Metronidazole 500mg BID for 10
days
Risk Assessment Negative for
STI
Risk Assessment Positive for STI
20. Patient complains of genital ulcer
Take history & examine
Vesicles Or Recurrence
Treat for HSV,
Treat for syphilis if indicated
•Educate and counsel
•Promote and provide condoms
•Offer VCT
•Ask the patient to return in 7 days
Ulcers healed
Educate and counsel
Promote and provide condoms
Offer VCT
Partner management
Ulcers and sores
Treat for syphilis,
chancroid and HSV
Educate
Promote and
provide
condoms
Offer VCT
Ulcers improving Refer
Continue treatment for further 7 days
No
No
Yes
Yes
Yes
Yes
No No
Genital Ulcer
Syndrome
21. 21
Genital Ulcer Disease Treatment
Recommended treatment for non-vesicular genital ulcer
Benzanthine penicilline 2.4 million units IM stat, or Doxycycline
100 mg bid for 15 days
and
Ciprofloxacin 500mg, po, bid for 3 days, or Erythromycin 500 mg,
po, QID for 7 days
Recommended treatment for vesicular or recurrent
genital ulcer
Acyclovir 200 mg five times per day for 10 days
or
Acyclovir 400 mg TID for 10 days
22. 22
HSV Spectrum of Disease
Persistent ulcerative HSV infections are very
common in AIDS
Candida and HSV often occur in association
Oral-facial
Primary: gingivostomatitis & pharyngitis
Reactivation: herpes labialis
Asymptomatic shedding is common
Thus, patients are potentially infectious even when
lesions are absent
24. 24
HSV in the
Immunocompromised Host
High frequency of reactivation
Increased severity
Widespread local extension
Higher incidence of dissemination
Viremic spread to visceral organs, which is rare
but can be life threatening
27. 27
HSV Treatment
Primary infection
Acyclovir 200 mg PO 5x/day for 7-14 days
or
Acyclovir 400mg PO tid for 7-14 days
or
Famciclovir 500 mg PO bid for 7-14 days
or
Valacyclovir 1 gm PO bid 7-14 days
Recurrences treated with same dosage, but may need
only 5-10 days therapy
Suppressive therapy may be indicated for patients with
frequent recurrences, BUT
Continued treatment risks developing resistant HSV
28. 28
Lower Abdominal Pain Due to PID
(Pelvic Inflammatory Disease)
PID is ascending infection of the upper genital
tract (uterus, tubes, etc) from the cervix and/or
vagina
Common etiologies:
Sexually transmitted: Neisseria gonorrhea, Chlamydia
trachomatis, Mycoplasma hominis
Others (non-STI): streptococci, E. coli, etc
Vaginal discharge is often present
29. 29
Patient complains of
lower abdominal pain
Take history including gynecological
and examine (abdominal and vaginal)
Any of the following present
•Missed overdue period
•Recent delivery/ abortion
•Miscarriage
•Abdominal guarding
•And or rebound tenderness
•Abdominal mass
•Abnormal vaginal bleeding
Refer the patient for surgical or
gynecological opinion
and assessment
Before referral set up
an Iv line and resuscitate
if required
Is there cervical excitation tenderness
Or lower abdominal tenderness
And vaginal discharge
Manage for PID
Review in three days
Continue treatment until completed
•Educate and counsel
•Offer VCT
•Promote and provide condom
•Ask patient to return if necessary
Patient has improved Refer patient
Manage
appropriately
Any other
illness
found
Lower Abdominal Pain
Yes
No
Yes
Yes
No
No
Yes
30. 30
Recommended Treatment for PID
Out patient Inpatient
Ciprofloxacin 500mg PO bid for 7
days, or Spectinomycin 2gm IM
stat
plus
Doxycycline 100mg BID for 14
days
plus
Metronidazole 500mg BID for 14
days
Ceftriaxone 250mg IV BID, or
Spectinomycin 2gm IM BID
plus
Doxycycline 100mg BID for 14
days
plus
Metronidazole 500mg BID for 14
days, or Chloramphenicol 500mg
IV QID
31. 31
Scrotal Swelling
Common STI causes of scrotal swelling are
similar to those of urethral discharge
Neisseria gonorrhea
Chlamydia trachomatis
Exclude non-STI causes of scrotal swelling:
TB
Inguinal hernia
Testicular torsion, etc
32. 32
Scrotal Swelling
Patient complains of
scrotal swelling or pain
Take history, examine,
offer HIV test
Scrotal swelling or
pain present?
History of trauma or testis
elevated or rotated?
or
Diagnosis in doubt?
Refer patient to
hospital
Signs of other
STI present?
Reassure patient, educate,
counsel, provide condoms.
Review if symptoms persist
Treat according to
appropriate flowchart
Treat for chlamydia
and gonorrhea.
Review in 7 days
Patient has improved?
Complete treatment course,
reinforce
education and counseling
Review if symptoms persist
Yes
Yes
No Yes
No
No
Yes
No
33. 33
Scrotal Swelling
Recommended Therapy
Ciprofloxacin 500mg PO stat or Spectinomycin
2gm IM stat
and
Doxycycline 100mg PO BID for 7 days, or
Tetracycline 500mg BID for 7 days
34. 34
Inguinal Bubo
Swelling of inguinal lymph nodes as a result of
STIs (or other causes)
Common causes:
Treponema pallidum (syphilis)
Chlamydia trachomatis (LGV)
Hemophylus ducreyi (chancroid)
Calymatobacterium granulomatis (granuloma
inguinale)
35. Inguinal Bubo
Patient complaining of
inguinal swelling
Take history
and examine
Ulcers
present
Treat for LGV, GI and chancroid
•Aspirate if fluctuant
•Educate on treatment compliance
•Counsel on risk reduction
•Promote and provide condoms
•Partner management
•Offer VCT if available
•Advise to return in 07 days
•Refer if no improvement
Any other
STI present
Use appropriate flow chart
•Educate
•Counsel
•Offer VCT
•Promote and provide condoms
Use genital ulcer flow chart
No No
Yes
Yes
No
Inguinal/femoral
bubo present?
36. 36
Inguinal Bubo
Recommended treatment:
Ciprofloxacin 500mg PO BID for 14 days
and
Erythromycin 500mg PO QID for 14 to 21 days
37. 37
Neonatal Conjunctivitis
Infection of the eyes of the neonate as a result of
genital infection of the mother, transmitted
during birth
Causes:
Neisseria gonorrhea
Chlamydia trachomatis
38. Neonatal Conjunctivitis
Neonate presents with eye discharge
Take history and examine child
Purulent conjunctivitis present?
Complete treatment course,
reinforce education and counseling
Review if necessary
Treat baby for gonococcal and
chlamydial opthalmia
AND
Treat mother and partner for gonorrhoea
and chlamydia
Educate and counsel
Review baby in 7 days or sooner
if symptoms worsen
Signs of other illness
present?
Treat appropriately
Reassure mother,
educate parents
Review if symptoms persist
Eye infection cleared?
No No
Yes
Yes
Review in
7 days
Yes
Refer for specialist opinion
and management
No
39. 39
Neonatal Conjunctivitis: Treatment
Treatment:
Spectinomycin 50mg/kg IM stat or ceftriaxone 125mg
IM stat
and
Erythromycin 50mg/kg PO in 4 divided doses for 10
days
May lead to blindness if not treated properly
40. 40
Key Points
STIs are among the most common causes of
illness in the world
Emergence and spread of HIV infection and
AIDS has major impact on the management and
control of STIs
STIs increase the acquisition and transmission
of HIV
HIV infection alters the clinical features and
response to therapy of STIs
41. 41
Key Points (2)
The syndromic approach to STIs management is
recommended by WHO
Syndromic management is simple, rapid and
inexpensive
Notes de l'éditeur
Notes:
Unit 13 should take approximately 1 hour to complete:
Step 1: Unit Introduction and Learning Objectives (Slides 1-2) – 5 minutes
Step 2: STDs and STIs Overview; Interaction between HIV and STIs (Slides 3-8) – 10 minutes
Step 3: Syndrome Approach; STI Syndromes (Slides 9-39) – 40 minutes
Step 4: Discussion of Key Points (Slides 40-41) – 5 minutes
Notes:
Step 1: Unit Introduction and Learning Objectives (Slides 1-2) – 5 minutes
Notes:
Step 2: STDs and STIs Overview; Interaction between HIV and STIs (Slides 3-8) – 10 minutes
Some people use the terms STI and STD interchangeably but they actually have different meaning.
Notes:
Social and economic consequences of STIs:
Husband abandoning infertile wives
Beatings and/or divorce
Financial burden of treating STIs and their complications
Antibiotic resistance making low cost regimens ineffective
Notes:
Mechanism:
Mucosal and skin barrier disruption
Inflammation increasing CD4 cell concentration in genital areas
Infection leading to increased HIV expression in genital secretions
Note:
Bacterial vaginosis and candidiasis are also common causes of reproductive tract infections (vaginal discharge), but are not sexually transmitted (currently debatable).
Notes:
Step 3: Syndromic Approach STI Syndromes (Slides 9-39) – 40 minutes
“Syndromic Management” contrasts with “Etiologic Management.” Whereas etiologic management focuses on identifying and treating a specific etiology causing clinical symptoms, syndromic management considers the likely causative agent(s) for a given clinical syndrome and treats accordingly, without regard for identifying the specific infection.
Benefits of etiologic management: focused, specific therapy, avoiding the cost and toxicity of unnecessary medications.
Benefits of syndromic management: laboratory testing not needed; treatment provided immediately, without need for lab results; effective in resource-limited settings.
Notes:
(Source: National Guideline for the Management of STIs, March 2005)
The gonococcal isolates in the validation study conducted by EHNRI/MOH in Ethiopia were uniformly sensitive to ciprofloxacin making it the drug of choice. However it can not be given for pregnant women and children, in which case Spectinomycin can be used.
Notes:
Recurrent discharge may reflect poor adherence to initial treatment regimen, e.g., due to GI upset.
Recurrent discharge may also reflect re-infection.
If neither of these seem to be present, treat for T. vaginalis.
T. vaginalis was found to be common (second among causes of urethral discharge) among Ethiopian men with urethral discharge syndrome as seen in the validation study conducted by EHNRI/MOH.
Treatment – Metronidazole 2g po, stat.
Source: Validation of STI Treatment Algorithms, 2003-2004, EHNRI/MOH
Note:
The first three are sexually acquired and the last two are endogenous infections
Note:
Risk factors include age <25, trading sex, multiple or new partners in the last three months
Source: National Guideline for the Management of Sexually Transmitted Infections, March 2005
Notes:
If assessment of risk for STI is positive likely etiologies include Neisseria, Chlamydia and Trichomonas and hence Ciprofloxacin or spectinomycin, doxycycline and metronidazole are drugs of choice respectively.
If assessment of risk of STI is negative, likely etiologies are Gardnerella and candida; the drugs of choice being Metronidazole and clotrimazole
Notes:
According to the validation study conducted by MOH/ EHNRI in Ethiopia, it was found out that in genital ulcer diseases, one or more pathogens were found in males and females in 76% and 82.45 of the cases respectively. HSV2 alone was the leading cause of GUD in both males and females, constituting 44% and 75.5% of cases respectively. But the prevalence of HSV2 as it occurs in combination with other pathogens or alone constituted 52% and 78.45% in males and females respectively. Altogether, HSV2 was responsible for 70% of all GUD causes. Syphilis was the second leading cause in males (28%) as compared with females (6%). Chanchroid constituted for only 4% of GUD cases. ( Source: Validation study of the syndromic algorithm approach of the management of STIs in Ethiopia , August 2004)
Source of above recommendations: National Guideline for the Management of STIs , March 2005, Ethiopia
Note:
In about 75% of EM, HSV is the precipitating event. Patients with severe HSV-associated Em should be on chronic oral suppressive Tx
Notes:
Persistence for >1 month is an AIDS-defining condition.
Chronic herpes simplex can be painful and debilitating involving not only the genital area but the mouth, lips, esophagus and skin. Treatment is available for suppression but can be very expensive and will need to be taken for a long time. These can last months and may be improved with ARV treatment. Herpetic lesions can also become secondarily infected leading to more morbidity in the HIV infected patient.
Note:
Herpes genitalis outbreak on the penile shaft due to HSV-2.
Note:
Source: 2004 medical management of HIV. John G Bartlett & Joel E. Gallant
Acyclovir, Famciclovir, and Valacyclovir are category B. Acyclovir is not teratogenic, but has potential to cause chromosomal damage at high doses. The CDC recommends use of acyclovir during pregnancy for severe HSV outbreaks and varicella. Use for prophylaxis in pregnancy is being investigated.
Notes:
Ask participants to identify what organisms are being treated with each antibiotic:
Ciprofloxacin, Spectinomycin, Ceftriaxone: Gonorrhea
Doxycycline: Chlamydia
Metronidazole, Chloramphenicol: Anaerobic (and other) bacteria
antibiotics have broader spectrum of action than just the organisms identified above, but this exercise helps reinforce what organisms cause PID, and the connection between causative agents and specific treatments.
Note:
Ciprofloxacin is indicated in Ethiopia for treatment of Gonorrhea
Notes:
Some experts advise treating inguinal bubo for three weeks
(Source national guideline for the management of STIs, March 2005)
Notes:
Spectinomycin 50 mg /kg im stat can be replaced for ceftriaxone for gonococcal ophtalmia in Ethiopian setting.
In the case of herpes conjunctivitis
Acyclovir 5-10 mg /kg iv daily for 10 days is indicated
Source: National Guideline for the management of STIs, March 2005